- A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL2016 | Faculty of Medicine in Hradec Králové
- A Phase 2/3, multicenter, randomized, double-masked, 2-year trial of pegaptanib sodium for the treatment of diabetic macular edema2011 | Publication without faculty affiliation
- A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma2017 | First Faculty of Medicine
- A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy2018 | First Faculty of Medicine
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia2010 | First Faculty of Medicine, Third Faculty of Medicine
- Current Clinical Practice in Cytoreductive Surgery for Advanced Ovarian Cancer A European Survey2011 | First Faculty of Medicine
- Výzkumná zpráva Fakultní nemocnice ke klinickému hodnocení M11-313Publication without faculty affiliation
- Research Report University Hospital of the clinical trial CC-5013-MCL-002Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 20060540Publication without faculty affiliation
- Research Report University Hospital for clinical assessment 20070622Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no; CSLCT-HDL-12-77Publication without faculty affiliation
- Research Report University Hospital clinical trial BO21005Publication without faculty affiliation
- Research Report University Hospital clinical trial AZA-MDS-003Publication without faculty affiliation
- Landiolol in patients with septic shock resident in a intensive care unit (LANDISEP): study protocol for a randomized controlled trial2018 | Publication without faculty affiliation
- A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and rationale for the ACCOAST study2011 | Third Faculty of Medicine
- The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods2017 | First Faculty of Medicine
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma2019 | First Faculty of Medicine
- ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease2021 | Second Faculty of Medicine
- Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: A phase II randomized clinical trial2014 | Publication without faculty affiliation
- Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial2021 | Second Faculty of Medicine
- Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)2021 | Publication without faculty affiliation
- Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants2021 | Faculty of Medicine in Hradec Králové
- Randomized Trial of Biosimilar XSB-001 versus Reference Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration2023 | Publication without faculty affiliation